• Restoring sanity to SA

    We should be driven by the thought that SA belongs to all who live in it, says Solly Moeng.

  • Clamouring for action

    2017 will see battles between politicians as well as those tired of politicking, says Daniel Silke.

  • Realistic dreaming

    Preparation and sound advice will turn entrepreneurial dreams into reality, says Ian Mann.

All data is delayed
Loading...
See More

Aspen finalises GSK deal for £164m

Dec 03 2012 08:22
Reuters

Shutterstock

Company Data

ASPEN PHARMACARE HOLDINGS LIMITED [JSE:APN]

Last traded 272
Change -1
% Change -1
Cumulative volume 1209085
Market cap 0

Last Updated: 07-12-2016 at 05:05. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Aspen boosts profit, Asian unit robust

Aspen buys GSK Aussie drugs for R2.2bn

Aspen unit to buy drug portfolio from GSK

Aspen prepared to help bridge ARV shortages

Aspen buys GSK brands

Aspen: Earning to between rise 18%-24%

 

Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on Monday it has finalised the acquisition of medicines from GlaxoSmithKline for £163.8m.

The deal, announced in August, was initially pegged at £172m.

 

NEXT ON FIN24X

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.
 

Company Snapshot

We're talking about: SMALL BUSINESS

From fossils to finance – that’s been the career trajectory of Dr Merrill van der Walt, a palaeontologist until recently. She is now a statistician with a difference.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

SA's avoidance of junk status by rating agencies: Moody's and Fitch

Previous results · Suggest a vote

Loading...